$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
The full version of the official instructions and medication guide for Shafinamide Tablets (Siddaco)
2026-02-01 22:25:32
Check Details
Analysis of whether Tarlatamab-Imdelltra is an immunological drug and its role in tumor treatment
2026-02-01 22:25:32
Check Details
Telisotuzumab-EMRELIS price in foreign markets and channels for purchasing imported drugs
2026-02-01 22:25:32
Check Details
A comprehensive analysis of the mechanism of action and indications of tovorafenib
2026-02-01 22:25:32
Check Details
Vorasidenib-VORANIGO tablet market reference price and drug purchasing channels
2026-02-01 22:25:32
Check Details
Full analysis of the domestic marketing status of Zongertinib (Zongatinib) and the ways it can be obtained by patients
2026-02-01 22:25:32
Check Details
Analysis of efficacy and clinical data three months after vosoritide injection
2026-02-01 22:25:32
Check Details
Analysis of common side effects and possible health hazards of Mecobalamin
2026-02-01 22:25:32
Check Details
What cancers does cobimetinib mainly treat and analysis of the corresponding target effects
2026-02-01 22:25:32
Check Details
How much does a box of macitentan tablets cost? Summary of selling prices in pharmacies in various regions
2026-02-01 22:25:32
Check Details
Is Pitolisant a self-paid drug or a medically insured drug?
2026-02-01 22:25:32
Check Details
Analysis of Pretomanid medical insurance coverage and patient purchasing guide
2026-02-01 22:25:32
Check Details
1
2
...
2272
2273
2274
2275
2276
2277
2278
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma